Sell KVUE by Oct 11, 2026.

Bloomberg reports that a US federal appeals court has revived lawsuits alleging that Kenvue Inc. failed to disclose purported risks associated with taking Tylenol during pregnancy. The claims allege that prenatal exposure to the over-the-counter pain reliever may be linked to autism and other developmental conditions in children. The allegations remain disputed and have prompted significant debate within the medical and scientific communities. According to Bloomberg, a three-judge appeals panel in New York ruled on Monday that the lower court …